AR014714A1 - Sales de cetoacidos y derivados de aminas, y su utilizacion para la preparacion de medicamentos - Google Patents

Sales de cetoacidos y derivados de aminas, y su utilizacion para la preparacion de medicamentos

Info

Publication number
AR014714A1
AR014714A1 ARP990101081A ARP990101081A AR014714A1 AR 014714 A1 AR014714 A1 AR 014714A1 AR P990101081 A ARP990101081 A AR P990101081A AR P990101081 A ARP990101081 A AR P990101081A AR 014714 A1 AR014714 A1 AR 014714A1
Authority
AR
Argentina
Prior art keywords
cetoacid
aminas
medicines
derivatives
salts
Prior art date
Application number
ARP990101081A
Other languages
English (en)
Original Assignee
Logeais Labor Jacques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Logeais Labor Jacques filed Critical Logeais Labor Jacques
Publication of AR014714A1 publication Critical patent/AR014714A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion tiene por objeto la utilizacion de los compuestos de la formula general (I) siguiente: (X) n1, Y, (Z) n2 en la cual -n1 y n2representan 0 o 1, - X representa un aminoácido natural, especialmente un aminoácido escogido entrela ornitina, la arginina, la lisina, histidina o laglutamina, - Y representa un cetoácido de la formula (II) siguiente R-CO-COOH.
ARP990101081A 1998-03-13 1999-03-12 Sales de cetoacidos y derivados de aminas, y su utilizacion para la preparacion de medicamentos AR014714A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9803155A FR2775901B1 (fr) 1998-03-13 1998-03-13 Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments

Publications (1)

Publication Number Publication Date
AR014714A1 true AR014714A1 (es) 2001-03-28

Family

ID=9524054

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101081A AR014714A1 (es) 1998-03-13 1999-03-12 Sales de cetoacidos y derivados de aminas, y su utilizacion para la preparacion de medicamentos

Country Status (20)

Country Link
US (1) US6429229B1 (es)
EP (1) EP1061909B1 (es)
JP (1) JP2002506816A (es)
AR (1) AR014714A1 (es)
AT (1) ATE218335T1 (es)
AU (1) AU2733699A (es)
BR (1) BR9909651A (es)
DE (1) DE69901689T2 (es)
DK (1) DK1061909T3 (es)
DZ (1) DZ2743A1 (es)
EG (1) EG24397A (es)
ES (1) ES2177250T3 (es)
FR (1) FR2775901B1 (es)
HK (1) HK1035856A1 (es)
MA (1) MA24775A1 (es)
PT (1) PT1061909E (es)
TN (1) TNSN99032A1 (es)
TW (1) TWI235059B (es)
WO (1) WO1999047134A1 (es)
ZA (1) ZA991982B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060128806A1 (en) * 1998-05-28 2006-06-15 Medical Research Institute Controlled release arginine alpha-ketoglutarate
EP1318801B1 (en) * 2000-09-19 2009-03-11 Dermal Therapy (Barbados) Inc. Topical analgesic compositions containing aliphatic polyamines and methods of using same
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
US7122578B2 (en) * 2001-09-11 2006-10-17 Alain Martin Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
PL372183A1 (pl) * 2005-01-11 2006-07-24 Sgp & Sons Ab Preparat przeciwnowotworowy oraz zastosowanie preparatu przeciwnowotworowego
US20110105617A1 (en) * 2005-01-11 2011-05-05 Sgp & Sons Ab Method for treatment of neoplastic diseases with alpha-keto glutarate and/or salts thereof
WO2009116546A1 (ja) * 2008-03-18 2009-09-24 国立大学法人 岡山大学 興奮性化学伝達調節剤およびそのスクリーニング法
FR2953719A1 (fr) * 2009-12-10 2011-06-17 Luc Cynober Nouvelles applications therapeutiques d'un complexe d'alpha-cetoglutarate et d'ornithine
EP2523669B1 (en) * 2010-01-11 2016-12-07 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
AU2011230580A1 (en) 2010-03-26 2012-10-11 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
PL2807178T3 (pl) 2012-01-26 2017-12-29 Inotek Pharmaceuticals Corporation Bezwodne polimorfy azotanu (2R,3S,4R,5R)-5-(6-(cyklopentyloamino)-9H-puryn-9-ylo)-3,4-dihydroksytetrahydrofuran-2-ylo)metylu i sposoby ich wytwarzania
US20140187815A1 (en) * 2012-12-28 2014-07-03 Guoji Zhang Process for preparation of l-arginine alpha-ketoglutarate 1:1 and 2:1
MX2015013234A (es) 2013-03-15 2016-04-15 Inotek Pharmaceuticals Corp Formulaciones oftalmicas.
EP3062766A1 (en) * 2013-10-29 2016-09-07 L'Oreal, S.A. Use of mono ornithine ketoglutarate (mokg)
CN106674057A (zh) * 2015-11-09 2017-05-17 江西乐维生物药业有限公司 L-精氨酸a-酮基异己酸盐的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3533M (fr) * 1964-03-05 1965-09-13 Logeais Labor Jacques Médicament pour le traitement des intoxications ammoniacales a base d'α-cétoglutarate de l (+) ornithine.
US4320146A (en) * 1978-03-17 1982-03-16 The Johns Hopkins University Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease

Also Published As

Publication number Publication date
MA24775A1 (fr) 1999-10-01
ATE218335T1 (de) 2002-06-15
EG24397A (en) 2009-04-27
DZ2743A1 (fr) 2004-09-05
JP2002506816A (ja) 2002-03-05
WO1999047134A1 (fr) 1999-09-23
EP1061909A1 (fr) 2000-12-27
ZA991982B (en) 1999-11-23
FR2775901A1 (fr) 1999-09-17
EP1061909B1 (fr) 2002-06-05
DE69901689D1 (de) 2002-07-11
TNSN99032A1 (fr) 2005-11-10
PT1061909E (pt) 2002-11-29
US6429229B1 (en) 2002-08-06
ES2177250T3 (es) 2002-12-01
AU2733699A (en) 1999-10-11
BR9909651A (pt) 2000-11-21
DE69901689T2 (de) 2003-01-30
FR2775901B1 (fr) 2000-07-21
TWI235059B (en) 2005-07-01
DK1061909T3 (da) 2002-09-23
HK1035856A1 (en) 2001-12-14

Similar Documents

Publication Publication Date Title
AR014714A1 (es) Sales de cetoacidos y derivados de aminas, y su utilizacion para la preparacion de medicamentos
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
DK1200418T3 (da) Nematodicide trifluorbutener
PT1193270E (pt) Pirrolobenzodiazepinas
PT758248E (pt) Formulacoes para o factor ix
HN1998000113A (es) Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
GT199700052A (es) Sales metanosulfonatode5-(2-4-(1,2-benzoisotiazol-3-il)-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-onadihidratadas
FI963169A0 (fi) Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
PA8559401A1 (es) Sales de acido succinico de 5,7,14-triazatetraciclo (10.3.1.0 2,11.0 4, 9)-hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
HN2002000198A (es) Composiciones farmaceuticas de amlodipina y atorvastatina
TR200002542T2 (tr) Meta-azasiklik amino benzoik asit bileşikleri ve bunların integrin antagonistleri olan türevleri
BR0204678A (pt) Inibidor de nf-kb contendo derivado de ácido benzóico substituìdo como ingrediente ativo
ES2108772T3 (es) Derivados de aminofosfonato substituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
ATE253359T1 (de) Antithrombotische mittel
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
DK1180094T3 (da) Kondenserede polycykliske aminosyrer som farmaceutiske midler
FI963168A (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia indaani-2-merkaptoasetyyliamiddisulfidijohdannaisia
UY27372A1 (es) Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
AR027446A1 (es) Enaminomas heterociclicas fenil-sustituidas
AR023479A1 (es) Formas cristalinas de la sal de sodio de 5-cloro-2-metoxi-n-(2-4-metoxi-3-metilaminotiocarbonilamino sulfonilfenil)etil)benzamida
MX9207426A (es) Inhibidores de la reductasa de la 5-alfa-testosterona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal